Literature DB >> 22901273

Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site.

Osamu Fukuchi, Ayana Suko, Hiroyuki Matsuzaki, Hiromi Baba, Hisatoshi Yoshida, Tsunemichi Takeuchi, Syunichi Odawara, Shunpei Fukuda, Takashi Hashimoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901273     DOI: 10.1111/j.1346-8138.2012.01645.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  6 in total

Review 1.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

2.  Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature.

Authors:  Michelangelo La Placa; Riccardo Balestri; Federico Tartari; Andrea Sechi; Francesca Ferrara; Camilla Loi; Annalisa Patrizi; Federico Bardazzi
Journal:  Dermatol Pract Concept       Date:  2019-04-30

3.  Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement.

Authors:  Silvia Lambiel; Pavel Dulguerov; Emmanuel Laffitte; Igor Leuchter
Journal:  BMJ Case Rep       Date:  2017-08-11

4.  Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.

Authors:  Coralie Zumelzu; Marina Alexandre; Christelle Le Roux; Patricia Weber; Alexis Guyot; Annie Levy; Françoise Aucouturier; Sabine Mignot-Grootenboer; Frédéric Caux; Eve Maubec; Catherine Prost-Squarcioni
Journal:  Front Med (Lausanne)       Date:  2018-09-27

5.  Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases.

Authors:  F Giurdanella; A M Nijenhuis; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

6.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.